Other data also suggest FABP4 was higher in type 2 diabetes patients compared to healthy individuals [62], and may present a biomarker for cardiovascular disease given its association with arterial stiffness, renal function, adiposity, and hypertriglyceridemia [63, 64]. Here, FABP4 is linked to cardiovascular disorder.